Clovis Oncology (CLVS) Misses Q4 EPS by 18c

Clovis Oncology (NASDAQ: CLVS) reported Q4 EPS of ($1.83), $0.18 worse than the analyst estimate of ($1.65).

For earnings history and earnings-related data on Clovis Oncology (CLVS) click here.

You May Also Be Interested In

• BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
• Flowers Foods (FLO) Misses Q2 EPS by 3c; Offers Guidance
• The Buckle (BKE) Tops Q2 EPS by 7c, Beats on Revenue